Wedbush Reiterates Outperform on Pharvaris, Maintains $42 Price Target

Benzinga Newsdesk www.benzinga.com Negative 83.9%

Neg 83.9% Neu 0% Pos 0%

Wedbush analyst Laura Chico reiterates Pharvaris (NASDAQ:PHVS) with a Outperform and maintains $42 price target.

Comments

No comments yet. Be the first!